https://sfth20260911074942.staging2.ydu.fr/docutheque/ 2022-02-03T10:27:28+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/hasansm-2014-recommandations-transfusion-de-globules-rouges/ 2017-06-08T15:59:23+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/2013-bon-usage-du-medicament-aod-dans-la-fa/ 2017-06-08T15:59:53+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/cnam-2015-references-juridiques-biologie-medicale/ 2017-06-08T16:00:29+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/2016-ct-idarucizumab/ 2017-06-08T16:01:06+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/2016-ct-rivaroxaban-traitement-tvp-ep-et-prevention-recidive/ 2017-06-08T16:01:33+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/hasansm-2015-recommandations-transfusion-de-plaquettes/ 2017-06-08T16:02:27+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/synthese-anticoagulant-lupique/ 2017-06-08T16:02:59+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/rapport-anticoagulant-lupique/ 2017-06-08T16:04:47+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/resume-medecine-generale/ 2017-06-08T16:05:29+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/recommandations-2/ 2017-06-08T16:06:13+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/recommandations-ansm-transfusion-pfc-2012-argumentaire/ 2017-06-08T16:07:38+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/recommandations-ansm-transfusion-pfc-2012/ 2017-06-08T16:08:09+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/recommandations-ansm-antiplaquettaires-2012/ 2017-06-08T16:08:32+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/recommandations-ansm-anticoagulants-2012/ 2017-06-08T16:08:57+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/pneumologie/ 2017-06-08T16:09:23+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/proctologie/ 2017-06-08T16:09:47+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/gastrologie/ 2017-06-08T16:30:44+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/urologie/ 2017-06-08T16:31:08+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/recommandations/ 2017-06-08T16:31:33+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/prevention-de-maladie-thromboembolique-veineuse-perioperatoire-obstetricale/ 2017-06-08T16:32:00+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/utilisation-thrombolytiques-pratique-medicale-courante/ 2017-06-08T16:32:50+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/recommandations-afssaps-transfusion-plaquettaire-2003-2/ 2017-06-08T16:33:16+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/recommandations-afssaps-transfusion-plaquettaire-2003/ 2017-06-08T16:33:40+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/les-recommandations/ 2017-06-08T16:34:04+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/gouin-thibault-i-lecompte-t-sie-p-siguret-v-heparine-derives-hepariniques-antagonistes-de-vitamine-k-maniement-surveillance-biologique/ 2017-06-08T16:34:45+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/documents-emis-a-lintention-medecins-generalistes/ 2017-06-08T16:35:09+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/synthese-des-recommandations/ 2017-06-08T16:36:23+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/recommandations-2000-utilisations-antivitamine-k-pratique-medicale-courante/ 2017-06-08T16:37:05+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/recommandations-has-2018/ 2017-06-08T16:37:30+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/tableau-de-synthese-references-bibliographiques-transport-pneumatique/ 2017-06-08T16:38:44+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/qualification-transport-pneumatique/ 2017-06-08T16:39:07+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/chirurgie-gestes-invasifs-naco-sfar-geht-2011/ 2017-06-08T16:40:19+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/referentiel-sfhgeht-auto-anticorps-anti-proteine-s/ 2017-06-08T16:40:43+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/referentiels-sfh-geht-hemophilie-acquise/ 2017-06-08T16:41:07+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/referentiel-sfh-geht-syndrome-catastrophique-antiphospholipides/ 2017-06-08T16:41:31+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/referentiel-sfh-geht-microangiopathies-thrombotiques/ 2017-06-08T16:42:04+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/mise-point-emc-adamts13-2011/ 2017-06-08T16:42:27+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/normes-dacceptabilite-hemostase-geht/ 2017-06-08T16:42:52+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/rapport-etude-ansm-juillet-2014/ 2017-06-08T16:43:41+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/documents-ansm-has-cnam/ 2017-06-08T16:44:06+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/rapport-ansm-traitements-anticoagulants-2014/ 2017-06-08T16:44:42+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/rapport-ansm-traitements-anticoagulants-2012/ 2017-06-08T16:45:06+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/etats-lieux-cnam-vente-daod-novembre-2013/ 2017-06-08T16:45:56+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/avis-ct-dabigatran-ptgpth/ 2017-06-08T16:46:54+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/avis-ct-dabigatran-fa-2012/ 2017-06-08T16:47:48+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/avis-ct-rivaroxaban-ptgpth/ 2017-06-08T16:48:38+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/avis-ct-rivaroxaban-fa-2012/ 2017-06-08T16:49:51+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/avis-ct-rivaroxaban-tvpep-2012/ 2017-06-08T16:52:02+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/texte-geht-apixaban-tests-dhemostase/ 2017-06-08T16:53:09+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/texte-geht-dabigatran-tests-dhemostase/ 2017-06-08T16:54:01+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/texte-geht-rivaroxaban-test-dhemostase/ 2017-06-08T16:54:55+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/naco-tests-dhemostase-stv2011/ 2017-06-08T16:56:26+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/rivaroxaban-pathologie-thromboembolique-veineuse-jmv2012/ 2017-06-08T16:58:03+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/propositions-gihp-2016-situations-durgence-dabigatran/ 2017-06-08T16:58:37+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/propositions-gihp-2015-chirurgies-gestes-programmes/ 2017-06-08T16:59:33+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/propositions-gihp-2013-situations-durgence-aod/ 2017-06-08T17:00:26+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/propositions-gihp-geht-2011-chirurgies-actes-invasifs-aod/ 2017-06-08T17:01:25+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/gfhtsfnv-2016-thrombolyse-intraveineuse-dun-infarctus-cerebral-chez-un-patient-sous-aod/ 2017-07-24T10:22:59+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/recos-sfar-2012-post-operatoire/ 2017-07-26T15:20:18+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/nomenclature/ 2017-08-11T09:23:41+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/comites-de-listh/ 2017-08-11T09:25:10+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/tableau-de-synthese-prelevement-transport-centrifugation-conservation/ 2017-09-15T13:16:22+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/argumentaire-recommandations-proposees-tableau-de-synthese/ 2017-09-15T13:16:56+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/gfht-2017-evaluation-of-dabigatran-rivaroxaban-and-apixaban-target-specific-assays-in-a-multicenter-french-study/ 2017-10-16T10:15:14+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/gfht-sfnv-2018-intravenous-thrombolysis-for-acute-ischaemic-stroke-in-patients-on-direct-oral-anticoagulants/ 2018-02-07T11:52:24+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/gfht-2017-prise-en-charge-des-thrombopenies-neonatales-avec-une-suspicion-dallo-immunisation-foetomaternelle/ 2018-11-07T15:50:14+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/gfht-2017-recommandations-texte-long-delais-de-realisation/ 2019-02-28T08:28:05+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/gfht-2017-tableau-delais-pre-ana-sang-total-et-plasma/ 2019-02-28T08:28:40+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/gfht-2017-tableau-de-synthese-delais-pre-ana-plasma-congele/ 2019-02-28T08:29:11+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/mhemo-crh-gihp-avril-2019-prise-en-charge-dune-personne-atteinte-dhemophile-a-avec-inhibiteur-traitee-par-emicizumab-hemlibra-dans-un-contexte-de-chirurgie-ou-dhemo/ 2019-07-13T13:58:21+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/dosage-de-lactivite-du-facteur-ix-chez-les-patients-hemophiles-b-substitues-proposition-du-groupe-bimho/ 2019-08-02T02:15:54+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/management-of-bleeding-and-invasive-procedures-in-haemophilia-a-patients-with-inhibitor-treated-with-emicizumab-hemlibra-proposals-from-the-french-network-on-inherited-bleeding-disorders-mhe/ 2019-08-02T02:17:08+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/dosage-de-lactivite-du-facteur-viii-chez-les-patients-hemophiles-a-substitues-propositions-du-groupe-bimho/ 2019-08-02T02:18:13+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/gihp-gfht-2019-diagnostic-et-prise-en-charge-dune-thrombopenie-induite-par-lheparine/ 2020-03-06T14:52:30+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/actualisation-des-propositions-pour-la-gestion-des-discordances-entre-linr-realise-au-laboratoire-et-linr-realise-en-automesure-avec-le-coaguchek%e2%93%a1/ 2020-04-07T14:22:46+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/gfht-bimho-emicizumab-treatment-impact-on-coagulation-tests-and-biological-monitoring-of-haemostasis-according-to-clinical-situations-bimho-group-proposals/ 2020-10-08T06:24:36+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/le-myelogramme-guide-de-bonne-execution-le-groupe-francophone-dhematologie-cellulaire-gfhc/ 2020-12-22T15:29:14+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/prise-en-charge-en-urgence-tvc-contexte-vaccination-anticovid-sfnv-sfmv-gfht-v2-02042021/ 2021-04-28T15:40:30+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/prise-en-charge-en-urgence-dune-thrombose-dans-un-contexte-de-vaccination-anti-covid-version-du-28-04-2021/ 2021-04-30T09:08:26+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/prevention-du-risque-thromboembolique-veineux-et-surveillance-de-lhemostase-chez-les-patients-hospitalises-pour-covid-19-propositions-reactualisees-avril-2021-gfht-gihp/ 2021-06-18T14:59:00+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/thrombopenie-neonatale-par-allo-immunisation-plaquettaire-foeto-maternelle-brochure-dinformation-a-destination-des-parents-version-mai-2021/ 2021-06-28T16:01:17+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/propositions-gfht-pour-le-maniement-de-largatroban-en-contexte-de-vitt-v2-juillet-2021/ 2021-07-24T19:29:46+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/thrombophilie-biologique-propositions-gfht-2020-2/ 2021-12-11T10:39:51+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/la-place-du-dosage-des-d-dimeres-en-medecine-document-medecins-sfmv-gfht-innovte/ 2021-12-17T08:14:15+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/stabilite-sang-total-et-plasma-hemostase-specialisee-dec-2018/ 2022-02-03T10:24:14+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/stabilite-plasma-congele-hemostase-specialisee-dec-2018/ 2022-02-03T10:25:30+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/stabilite-plasma-congele-et-delais-de-realisation-des-parametres-dhemostase-generale-mai-2017-mis-a-jour-decembre-2018/ 2022-02-03T10:26:12+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/stabilite-sang-total-et-plasma-et-delais-de-realisation-des-parametres-dhemostase-generale-mai-2017-mis-a-jour-decembre-2018/ 2022-02-03T10:26:45+00:00 https://sfth20260911074942.staging2.ydu.fr/docutheque/recommandations-pre-analytiques-en-hemostase-tableau-de-synthese-octobre-2015-mise-a-jour-2018/ 2022-02-03T10:27:28+00:00